Davide P.

Davide P. is a co-founder of Biotix since January 2021, with extensive experience in the fields of biology and clinical research. Prior to this role, Davide served as Biological/Clinical Lead at Sensyne Health, focusing on clinical AI and health device development. As a Senior Scientist at Adaptimmune from September 2016 to August 2019, contributions included leading cross-functional projects in T cell therapy for cancer treatment. Davide's prior academic roles include Associate Researcher at King's College London, where investigations centered on the microbiome's role in skin conditions, and Research Fellow positions at Technische Universität München and Imperial College London, exploring T cell subsets in asthma and other allergic conditions. Educational qualifications include a Ph.D. in Experimental Medicine/Immunology from the Technical University of Munich and a Master’s Degree in Biotechnology Pharmaceutical from Università degli Studi di Napoli Federico II.